Prostate Cancer: Better Living Through Biomarkers
Doc Wire News,
One scientific session at the 2021 ASTRO annual meeting was dedicated to reports of studies of the use of biomarkers and…
One scientific session at the 2021 ASTRO annual meeting was dedicated to reports of studies of the use of biomarkers and…
12 hours ago 1 Views An update to the NCCN Clinical Practice Guidelines for Oncology recommends using the Decipher Prostate…
NEW YORK (Reuters Health) - The Decipher genomic classifier (GC) is a promising tool to help determine which men will benefit…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
In this study, the Decipher Prostate RP, a radical prostatectomy post-surgery test, was clinically validated to predict overall…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ --, a commercial-stage precision oncology company committed to improving patient care…
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ --, a commercial-stage precision oncology company committed to improving patient care…
Decipher test validated in study of the practice-changing Phase 3 RTOG 96-01 clinical trial SAN DIEGO, Feb.
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, a commercial-stage precision oncology company committed to…
Decipher Test Clinically Validated as a Predictor of Overall Survival in Men with Prostate Cancer Decipher test validated in…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
Credit: CC0 Public Domain A commercially available genomic test may help oncologists better determine which patients with…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
Oncology/Hematology > Prostate Cancer Another step toward personalized therapy? by Contributing Writer, MedPage Today February…
Newswise — A commercially available genomic test may help oncologists better determine which patients with recurrent prostate…
Post Views: 1 A commercially available genomic test may help oncologists better determine which patients with recurrent…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may…
SAN DIEGO, Feb. 11, 2021 /PRNewswire/ -- Decipher Biosciences, Inc., a commercial-stage precision oncology company committed to…